We have characterized the expression and activity of the cell cycle regulatory machinery and the organization of the cytoskeleton of the p16 Ink4a
Introduction
Progression through the G 1 phase of the cell cycle is controlled, in part, by the regulation of activity of cyclin-dependent kinases (cdk's) (for review, see Weinberg, 1995) . One important means of regulating cdk activity occurs through the formation of complexes comprised of the cdk's and the cyclin-dependent kinase inhibitors (CKI's). The activities of these CKI's include binding to cyclin/cdk co-complexes and inhibition of their associated kinase activity (for review, see Sherr and Roberts, 1995) , binding to speci®c cdks and subsequent inhibition of their association with cyclins (Parry et al., 1995) and, paradoxically, promotion of the formation of some cyclin-cdk complexes (LaBaer et al., 1997) . So, for example, in response to DNA damage, p53 induces expression of the CKI protein, p21
Cip1/Waf1 (p21), leading to inhibition of activity of multiple cyclin/cdk co-complexes El-Deiry et al., 1993; Harper et al., 1993; Waldman et al., 1995) . p27
Kip1 (p27) contributes to the growth suppressive signals from TGF-b or cell-cell contact (Hengst et al., 1994; Polyak et al., 1994a,b; Reynisdottir et al., 1995; Toyoshima and Hunter, 1994) and inhibition of its expression by antisense oligonucleotides prevents G 1 arrest in response to mitogen depletion (Coats et al., 1996) . The importance of p27 in regulating cell growth has recently been appreciated from studies which examined the phenotype of mice de®cient for this CKI (Fero et al., 1996; Kiyokawa et al., 1996; Nakayama et al., 1996) . Mice nullizygous for p27 exhibit hyperplasia in multiple organ systems due to failure to exit the cell cycle during terminal dierentiation. The loss of p27 is also associated with neoplastic transformation of the pituitary gland, consistent with the notion that p27 functions as a tumor suppressor.
Loss of another CKI, p16 Ink4a (p16), has also been implicated in malignant transformation (Kamb et al., 1994; Serrano et al., 1993 Serrano et al., , 1996 . Although not associated with the generalized hypertrophy of the p27 knock-out mice, p16-de®cient mice exhibit a number of soft tissue sarcomas and are highly susceptible to radiation and carcinogen-induced tumors (Serrano et al., 1996) . Loss of p16 expression has also been implicated in human cancers due to its high frequency of deletion or mutation in melanomas, pancreatic adenocarcinomas, leukemias and malignant astrocytomas (Caldas et al., 1994; Hussussian et al., 1994; Ichimura et al., 1996; Jen et al., 1994; Kamb, 1995; Kamb et al., 1994; Liu et al., 1995; Schmidt et al., 1994) .
We have been studying cell cycle regulatory pathways in the p16-de®cient, malignant astrocytoma cell line, U343 MG-A (U343). Retinoic acid (RA) treatment of these cells inhibits proliferation, alters morphology, and increases the expression and organization of a marker of glial dierentiation, glial ®brillary acidic protein (GFAP) (Rutka et al., 1988) . In the present study, we sought to determine the relationship between RA-induced dierentiation and the expression of several key cell cycle regulators. We show that whereas both CKI-induction and RA treatment can independently cause U343 cells to arrest in G 1 phase, the cell morphologies resulting from each treatment are markedly dierent. Our data demonstrate further that when p16-, p21-or p27-induced cell cycle arrest is accompanied by RA treatment, a profound phenotypic change in U343 astrocytoma cells occurs, cells becoming morphologically indistinguishable from primary astrocytes.
Results

Retinoic acid alters the morphology and growth characteristics of U343 cells
The p16-de®cient, human astrocytoma cell line U343 responds to all-trans RA treatment (Rutka et al., 1988) . Figure 1 shows that RA inhibits U343 proliferation ( Figure 1a ) and induces morphological changes (Figure 1b ± c) . So, rather than the tightly packed`cobble-stone' appearance of untreated cells (Figure 1b) , RA causes cells to elongate and acquire a somewhat bipolar appearance (Figure 1c ). Occasional long processes (510% of cells) are also observed in these RA treated cultures. The altered morphology in RA-treated U343 cells is accompanied by changes in cytoskeletal protein assembly (Figure 2 ). For example, untreated U343 cells exhibit diuse cytoplasmic and prominent perinuclear cytoplasmic staining for GFAP (Figure 2a ). This disorganized pattern of expression is replaced by a ®lamentous arrangement of GFAP staining in the cytoplasm and processes of RA-treated cells (Figure 2b ). The RA-induced reorganization of GFAP is also accompanied by changes in its apparent phosphorylation state. Using a phospho-GFAP-speci®c monoclonal antibody, YC-10, which recognizes phosphoserine in the context of a ten amino acid peptide of the GFAP amino-terminus (Matsuoka et al., 1992; Yano et al., 1991) , we show that a prominent punctate or speckled staining pattern is evident both in the cytoplasm and the nucleus of untreated cells (Figure 2c ± d) . This punctate staining pattern is lost in the cytoplasm but not in the nucleus of U343 cells treated with RA. Thus, RA-induced reorganization of the U343 astrocytoma cytoskeleton is accompanied by a loss of the phosphorylated form of GFAP from the cytoplasm.
RA treatment alters the expression and activity of cell cycle regulatory proteins
We next determined if the G 1 arrest following RA treatment is accompanied by changes in the expression and activity of cell cycle regulatory factors, speci®cally, the G 1 cyclins, their associated kinases and kinase inhibitors (Figure 3 ). The steady state protein levels of cdk1, cdk2, cdk4, and cdk6 do not change with RA treatment. In the case of the CKI, p21, induction occurs with slightly increased kinetics in RA-treated relative to untreated U343 cells. In contrast, expression of p27 is ®vefold higher in day 5 RA-treated cells compared to untreated U343 cells. This level of p27 in day 5 RA-treated cells is reached in untreated cells only after day 9 where proliferation of these cells has slowed (data not shown). Following RA treatment, cyclin D1 protein shows no change whereas cyclins A and E gradually decrease (data not shown).
The altered kinetics of p27 induction following RA treatment suggested that the kinase activity associated with the cdk's would also be inhibited in U343 cells. Thus, cdk2 or cdk4 were immunoprecipitated from RA-treated or untreated U343 cells. Their associated kinase activity was then determined in in vitro kinase assays using histone H1 or puri®ed human recombinant full length pRB, respectively, as substrates. As the right panels in Figure 3 demonstrate, the kinase activity associated with cdk2 is strongly inhibited by day 5 of RA treatment, the point at which both p21 and p27 are strongly induced. In the case of cdk4, however, only a minor but consistent reduction in its associated kinase activity is seen in these RA-treated cells. Thus, the proliferative block induced in U343 cells appears to be associated with p21 and p27 induction and a commensurate inhibition of cdk2, but not cdk4, associated kinase activity. This block is associated with a morphological change in U343 cells In vitro kinase assays demonstrate that cdk2-associated kinase activity is absent by day 5 in RA-treated cells. In contrast, only a small but consistent decrease in cdk4-associated kinase activity is seen with RA treatment which is distinct from untreated cells and from normal astrocytes.
Eect of induced CKI expression on U343 astrocytomas
The morphological changes and cell cycle arrest caused by RA were associated with induction of p21 and p27. We wished, therefore, to determine if CKI-induced cell cycle arrest would also alter U343 cell morphology and would aect the outcome of RA treatment. Thus, p16, p21 and p27 under the control of the tetracyclinerepressor (tet R ) expression system (Gossen and Bujard, 1992; Resnitzky et al., 1994) were individually introduced into U343 cells. Several lines were isolated where tight tetracycline-dependent control of CKI expression could be demonstrated. All of the lines for each CKI behaved identically and a representative line for each is presented in Figure 4 . Figure 4a , c and e demonstrate the regulated expression of p16, p21 and p27, respectively, using the tet R system. For all three CKI's little or no detectable expression is seen under repressed condi- tions (+). In contrast, within 24 h of removing tet (7), expression of all three CKI's can be detected. Expression reached maximal levels for all three CKI's near day 5 following induction. As expected, expression of p16, p21 or p27 produced a potent proliferative block in U343 cells (Figure 4b, d and f, respectively) . In all three cases, no increase in cell numbers were observed after day three following removal of tet. Table 1 demonstrates further that by day 5, the majority of the cells are blocked in G 1 in the p16 and p27 arrested cells. In the case of p21, we consistently observe that a signi®cant fraction of these cells are arrested in the G 2 /M portion of the cell cycle.
We next determined the eect of CKI induction on the expression and activity of factors in¯uenced by the CKI's, speci®cally the cdk's, the pRB-and the E2F-family proteins. Figure 5a illustrates the expression pattern of cell cycle regulatory proteins during p16 induction. The three pRB-family proteins, pRB, p107 and p130 are primarily hyperphosphorylated in uninduced cells (day 0) but are found exclusively in their hypophosphorylated forms by day 3 of p16 induction. Additionally, pRB and, more dramatically, p107 are reduced in levels in these cells while p130 is induced as p16 expression increases. E2F-1, which like p107 and pRB contain E2F-binding sites in their promoter regions (Shan et al., 1994) , is strongly repressed following p16 expression. In contrast, E2F-4, which is the predominant E2F-family member associated with p130 in quiescent cells (Cobrinik et al., 1993; Smith et al., 1996; Vairo et al., 1995) , increases slightly in these cells. , there is a decrease in expression of pRB and p107, with shift to the hypophosphorylated form. p130 is also shifted from four identi®able forms to two hypophosphorylated forms but its levels are increased as p16 is induced. E2F-1 protein is also decreased to almost undetectable levels while E2F-4 levels remain constant. Western blot analysis for cdk2, cdk4 and cdk6 showed little variation in steady state levels of these proteins following p16 induction. The Western blot for cdk2 reveals a loss of the active, hyperphosphorylated form of cdk2 (lower band) and shift exclusively to the slower migrating, hypophosphorylated form. (b) Kinase activity associated with cdk2, cdk4 and cdk6. As expected, cdk2 shows a strong decrease in the associated kinase activity as cells become growth arrested. In contrast, we consistently observe little change in the kinase activity associated with cdk4 and cdk6. The level of non-speci®c kinase activity for cdk4 was con®rmed by addition of a blocking peptide (lane P)
The bottom row of Western blots in Figure 5a demonstrates that little change in the levels of cdk2, cdk4 and cdk6 occur in these p16-arrested cells. Cdk2 does, however, undergo a signi®cant change in mobility in SDS ± PAGE. Speci®cally, in exponentially growing p16-de®cient cells (day 0), cdk2 migrates as two species, a faster migrating, hyperphosphorylated form, which is the active form of cdk2 and a slower, inactive hypophosphorylated form (Poon and Hunter, 1995) . When U343 cells become arrested following expression of p16, the active, hyperphosphorylated form of cdk2 is lost. It should be noted further that neither p21 or p27 were induced in the p16-arrested cells (data not shown). The kinase activity associated with cdk2, cdk4 and cdk6 were also determined ( Figure 5b) . As expected, cdk2 shows a strong decrease in the associated kinase activity as cells become growth arrested. In contrast, we consistently observe little change in the kinase activity associated with cdk4 and cdk6. The same antibodies for cdk4 and cdk6 detected changes (decreased) in associated kinase activity for these two cdk's when isolated from exponentially growing and dierentiated myoblasts (C 2 C 12 cells). The persistence of cdk4-associated kinase activity in these cells was also veri®ed using three independent antibodies (data not shown).
The phosphorylation state of the pRB-family proteins is also altered in the p21 and p27-induced cells. A representative Western for pRB is seen in Figure 6a . Like the cells where p16 is induced, pRB becomes primarily hypophosphorylated and its levels repressed following p21 or p27 induction. The kinetics of this transition for the p21/p27-induced cells is slightly delayed relative to eects induced by p16. p107 levels are also repressed following both p21 and p27 induction. In the case of p130, p21-expressing cells have increased levels of p130 while little change in p130 was observed in p27-arrested cells. As with p16-induced cells, expression of E2F-1 was sharply reduced and E2F-4 levels were unchanged in p27 and p21-induced cells (data not shown). For p27-arrested cells, the kinase activity associated with cdk2 and cdk4 is similar to that observed for cells arrested following p16 expression (data not shown).
CKI expression during RA-stimulation induces unique morphological and cytoskeletal changes in U343 astrocytomas
The cell cycle arrest associated with p16, p21 or p27 induction in U343 astrocytomas is accompanied by a strong morphological transition. All three CKI's induced identical morphological and cytoskeletal alterations and these changes could be reversed by repressing CKI expression by adding tet back to the media. Figure 7 illustrates the gross morphological changes associated with CKI expression, p16 used here as an example. Figure 7a shows the usual`cobblestone' appearance of U343 cells when p16 expression is repressed. Following p16 expression, however, the cells atten and contain abundant cytoplasm which has a large number of vacuoles around the nucleus. Thesè pancake'shaped cells are in marked contrast to the elongated cells observed following RA-dependent cell cycle arrest (see Figure 7c) . We next wished to determine if the CKI-arrested cells, when treated simultaneously with RA, would resemble cells treated with RA exclusively. As Figure 7d illustrates, the combination of a strong proliferative block imposed by p16 in the presence of RA stimulation caused a unique morphological transition. Rather than elongate into cells with a bipolar appearance, these p16-induced, RA-treated cells formed numerous long processes. These processes migrated in many directions and typically made contacts with other processes and cell bodies in the dish. These cells, in fact, resembled the morphology of primary astrocytes grown in culture. The same morphological changes shown in Figure 7 for p16 were seen in U343 cells expressing p21 and p27, either alone or in conjunction with RA treatment. Under all of these conditions, cells were viable for greater than 21 days and these eects were reversible after as long as 14 days following CKI-induction/RAtreatment (data not shown). The return to the usual appearance and proliferative state of U343 cells was not accompanied by any obvious increase in cell death. The profound morphological changes associated with CKI induction and simultaneous RA treatment indicated that important alterations in the U343 cytoskeleton had occurred. We ®rst examined the expression of the glial/astrocyte-speci®c protein, glial ®brillary acid protein (GFAP; Figure 8 ). In proliferating U343 cells, this intermediate ®lament is highly disorganized, appearing as a diuse, cytoplasmic factor. Induction of the CKI's (p21 in this case), clearly results in an altered arrangement of GFAP (Figure 8, middle panel) . The`pancake' appearance of these cells can easily be appreciated and a ®ne ®lamentous arrangement of GFAP radiating outward is observed. When the U343 cells are arrested with p21 and treated with RA, GFAP acquires a distinct arrangement. Under these conditions, a ®lamentous pattern is still evident in the cell bodies, but GFAP also shows very strong localization to the long processes that have formed under these conditions (Figure 8 , lower panel). This ®gure also illustrates the parallel arrangement of processes that are often seen in these cultures.
We next examined the expression of actin and the intermediate ®lament protein, vimentin ( Figure 9) . As with the pattern of staining for GFAP, both vimentin (green) and actin (red) show diuse, disorganized staining patterns in U343 astrocytomas (Figure 9a ). p16 induction (Figure 9b ) causes a strong rearrangement of actin, the radial staining pattern reminiscent of GFAP in these same cells, while vimentin only shows limited organization. RA treatment (Figure 9c ) causes reorganization of both actin and vimentin, well de®ned ®laments clearly visible for both of these proteins. ment of both actin and vimentin occur in p16 induced cells treated simultaneously with RA. Speci®cally, ®ne actin ®laments are seen extending into the long processes that form in these cells. More dramatically, the vimentin signal, which was originally con®ned to the cytoplasm in a perinuclear pattern, is now observed at the tips of the processes of these cells. Vimentin is also localized to a region in the cell body in these RA treated, p16-arrested astrocytomas, this localization being apparently discontinuous with the vimentin at the tips of the processes. The pattern of staining for vimentin and actin in p16-induced, RA-treated U343 cells is more interesting given their staining pattern in normal, primary human astrocytes (Figure 9e ). In the astrocytes, vimentin is also localized to the tips of the processes which extend from the cell bodies and, discontinuously, in the cytoplasm in a discrete area. Actin is also highly organized in astrocytes, ®laments seen extending into the long processes. These data suggest that the malignant astrocytoma, U343 can be induced to phenotypically resemble quiescent primary human astrocytes only when a potent proliferative block, provided by CKI expression, and stimulation with RA occur together.
Discussion
Our study demonstrates that induced expression of p16, p21 or p27 in the p16-de®cient astrocytoma, U343, in the presence of retinoic acid causes these malignant cells to morphologically resemble primary human astrocytes. The morphological changes in U343 induced by p16, p21 or p27 alone do not resemble normal astrocytes nor does induction with retinoic acid alone. Rather, expression of a predominantly astrocytic phenotype with multiple long cytoplasmic processes occurs only when a strong proliferative block imparted by p16, p21 or p27 expression is accompanied by RA stimulation. Thus, in the absence of a signal from a morphogen (i.e. RA), cell cycle arrest is insucient to cause U343 cells to resemble primary astrocytes.
It is now well established that cell cycle arrest is associated with CKI-dependent inhibition of cdk activity. Cell cycle arrest is thought to be a requirement for terminal dierentiation. Ectopic expression of CKI's in undierentiated cells can lead to the limited expression of dierentiation markers or to morphologic changes of the dierentiated phenotype. For example, Vitamin D 3 treatment of U937 leukemia cells causes induction of p21 and p27 mRNA followed by expression of mRNA for macrophage markers (Liu et al., 1996) . Transfer of p21 or p27 into undierentiated U937 cells causes an increased expression of CD11b+ and CD14+ cells, suggesting that CKI expression alone is sucient to induce dierentiation in these cells. However, whereas nearly 100% of U937 cells express CD11b+ and CD14+ after vitamin D3 treatment, only 20 ± 35% express these markers after p21 or p27 transfer, and 30 ± 45% do so after co-transfection with p21 and p27. Similarly, DMSO treatment of mouse neuroblastoma cells causes an increase in p27 expression, a shift of pRB to the hypophosphorylated form, and morphologic differentiation (Kranenburg et al., 1995) . Transfection of p27 into these undierentiated cells, however, results in only 50% of the cells undergoing a similar morphologic change suggesting that induction of CKI expression alone is inecient at causing phenotypic differentiation.
It is also clear from our study, however, that RA treatment alone of U343 cells only weakly causes a change in morphology of these cells. We suggest that RA-treated U343 cells may represent an intermediate phenotype. The transition to a phenotype resembling primary astrocytes requires a strong block to cell cycle progression normally imparted by p16
Ink4a
. Since U343 cells are p16
-de®cient, only a potent block to proliferation imparted by the induced expression of p16, p21 or p27 causes these cells to acquire the astrocytic phenotype.
We con®rmed that the architecture of the CKIinduced and/or RA-treated cells resembled primary astrocytes by examining the arrangement of GFAP, vimentin and actin. The disorganized state of these structural proteins is radically altered in response to untreated p21 alone p21+RA Figure 8 Rearrangement of GFAP in CKI-expressing U343 cells. U343 cells expressing p21 are shown stained for GFAP. An extensive ®lamentous pattern is seen in these large,¯at cells relative to untreated cells. Following p21 expression and RA treatment, GFAP staining reveals the dramatic morphological changes of malignant U343 cells. Cells form many long processes, these processes often migrating in the same direction and in bundles. The processes also form contacts with other cells or processes. The phenotypic changes described here for p21 induction in the presence and absence of RA are identical to the changes observed following p16 or p27 expression in the presence or absence of RA. Immuno¯uorescence microscopy, 6780 (top), 6630 (middle and bottom) Figure 9 Vimentin and actin staining in U343 cells and primary astrocytes. (a) Control U343 astrocytoma cells with typical polygonal morphology. Vimentin immunoreactivity is present in a ®ne trabecular pattern throughout the cytoplasm, and actin is distributed beneath the surface of the cell membrane. Immuno¯uorescence confocal microscopy, 6470. (b) p16-induced U343 astrocytoma cells. A typical large¯at cell is observed. Vimentin immunoreactivity is sparsely dispersed throughout the expanded cytoplasm, but actin is expressed in radial arrays from the cell nucleus reminiscent of stress ®ber formation 6470. (c) RA-treated U343 astrocytoma cells. The cells have become broadly bipolar, vimentin is found throughout the cytoplasm, and actin is expressed in a ®lamentous pattern in the cell cytoplasm, 6380. (d) RA-treated, p16-induced U343 astrocytoma cells. Speci®cally, ®ne actin ®laments are seen extending into the long processes that form in these cells. Vimentin, originally con®ned to the cytoplasm in a perinuclear pattern, is now observed at the tips of the processes of these cells. Vimentin is also localized to a region in the cell body in these RA treated, p16-arrested astrocytomas, this localization being apparently discontinuous with the vimentin at the tips of the processes. The pattern of staining for vimentin and actin in p16-induced, RA-treated U343 cells resembles their staining pattern in normal, primary human astrocytes, 6600. (e) Primary human astrocytes in culture. In primary cultured astrocytes, vimentin is also localized to the tips of the processes which extend from the cell bodies and, discontinuously, in the cytoplasm in a discrete area. Actin is also highly organized in these astrocytes, ®laments seen extending into the long processes. Multiple long, tapering cytoplasmic processes are seen which stain intensely for vimentin, 6600 CKI-mediated cell cycle arrest. In fact, in data we have not shown, the phosphorylated form of GFAP, which can be detected in both the nuclear and cytoplasmic compartments of U343 cells, speci®cally disappears from the nuclear compartment upon CKI expression. These data and those described above clearly demonstrate that the activity of the cell cycle machinery can aect cellular architecture and in¯uence the organization of speci®c cytoskeletal components. The most dramatic reorganization of an intermediate ®lament was observed for vimentin. Slight reorganization of vimentin occurs in response to RA treatment or CKI expression alone. However, when both signals are provided, vimentin localizes to the tips of the newly formed processes in these cells. This arrangement of this intermediate ®lament is indistinguishable from its subcellular location in primary human astrocytes. Thus, we conclude that an astrocytic phenotype can be induced in malignant U343 cells when provided with both a strong proliferative block and a morphogenic signal. It will be interesting to determine if the relocalization of vimentin occurs in response to reorganization or expression of, as yet, unidenti®ed factors which promote process outgrowth and/or attachment, such as neural adhesion molecules or integrins.
Materials and methods
Cell culture
The well characterized U343MG-a (U343) malignant astrocytoma cell line was established from a primary malignant astrocytoma in an adult. This particular cell line is a subclone of the original tumor that stably expresses the astrocyte dierentiation marker, glial ®brillary acidic protein (GFAP). U343 grows adherently in a-MEM supplemented with 10% fetal bovine serum and penicillin/streptomycin/fungizone (Gibco BRL, Gaithersburg, MD, USA). A culture of primary astrocytes was established from a cortical resection of human brain performed due to a seizure disorder.
For dierentiation 2.5 ± 5610 5 cells were plated in 10 cm 2 dishes. All trans retinoic acid (RA) (Sigma, St Louis, MO) was added from 5610 73 M stock solution in 100% ethanol to a ®nal concentration of 5610 76 M. Control cells were cultured in 0.1% ethanol. The medium was changed every other day during the course of all experiments.
Cell proliferation assay
Cell growth was assayed by counting cells at de®ned intervals. Brie¯y, cells were trypsinized and resuspended in media, and an aliquot of cells was counted using a hemocytometer. Each count represented an average of ®ve counts on three separate determinations. Cell proliferation assays were repeated in triplicate.
Flow cytometric analysis
To determine the proportion of cells present in a particular cell cycle phase,¯ow-assisted cell sorting analysis (FACS) of DNA content was performed. Brie¯y, 0.2 ± 1610 6 cells were trypsinized, washed in phosphate buered saline (PBS), and resuspended in ice cold 80% ethanol. Cells were kept at 48C on ice until propidium iodide (PI) DNA staining was performed. For dierent samples the concentration of cells was kept equivalent. For staining, ®xed cells were resuspended in PI and DNAse-inactivated RNase A (®nal concentration 1 mg/mL) and were incubated for 30 min at room temperature in the dark. Stained cells were ®ltered through mesh capped tubes and DNA content was analysed on Becton-Dickinson FACScan. Percent cell cycle phase was determined using Cell Fit software (Becton-Dickinson).
Antibodies
Antibodies to cyclin A, cyclin E, cyclin D1, cdk1, cdk2, cdk4, cdk6, E2F1 and E2F4 were obtained from Santa Cruz Biotech. (Santa Cruz, CA) and to pRB and p16 from Pharmingen (San Diego, CA). a-p21 and a-p27 antibodies were obtained from Upstate Biotechnology Inc. (Lake Placid, NY). Antibodies speci®c for GFAP were obtained from Dako Inc. (Denmark), and vimentin and phalloidinrhodamine were obtained from Sigma (St Louis, MO, USA), whereas the phosphorylated GFAP antibody (YC-10) was from Medical and Biological Laboratories Co., Ltd. (Nagoya, Japan).
Western blots
Total cell lysates (10 ± 30 mg) were subjected to SDS ± PAGE. Proteins were transferred to polyvinylidene di¯uoride (Immobilon P) membranes by semi-dry transfer. Blots were rehydrated prior to immunodetection, and then were blocked in 5% skim milk in PBS/0.1% Tween 20 at room temperature for 1 h. Primary and secondary antibody incubations were performed in blocking solution at room temperature for 1 h. Goat anti-rabbit or mouse horseradish peroxidase conjugated secondary antibodies were used at 1 : 5000 ± 1 : 8000 concentrations. Detection was performed using the enhanced chemiluminescence system (ECL, Amersham, Oakville, ON).
Immuno¯uorescence and confocal microscopy
Glass cover slips with cells from each treatment group were permeabilized with 0.02% triton6100 for 5 min prior to ®xation with 4% paraformaldehyde in 0.1 M phosphate buer (PH 7.2) for 30 min. They were then washed several times with PBS and the residual aldehyde blocked with PBS containing 0.5% BSA and 0.15% glycine. Following several rinses in PBS with 0.5% BSA, the cells were incubated with a monoclonal antibody against vimentin or the polyclonal antibody for GFAP for 1 h. Rhodamine phalloidin was used for actin staining for 30 min. Specimens were then washed thoroughly with PBS prior to incubation with the secondary antibody, a goat antimurine or anti-rabbit IgG conjugated to FITC or rhodamine (Molecular Probes, Eugene, OR), for 1 h. After a thorough washing, the coverslips were mounted on glass coverslips with mounting medium (Inova Diagnostics, San Diego, CA). Irrelevant antisera or the omission of primary antibody were used as controls. Specimens were then examined under a Leica TCDS 4D confocal laser scanning microscope. 0.5 mm optical sections were obtained and viewed as single planes. In addition, data sets from each cell were rendered as a stacked perspective of all the optical sections. GFAP stains shown were examined with a Leica immuno¯uorescence microscope.
Histone H1 and pRB kinase assays
Histone H1 and pRB kinase assays were performed according to the protocol of Matsushime et al. (1994) . For pRB kinase assays, a human recombinant full length pRB was used as a substrate (QED Advanced Research Technologies Inc., San Diego, CA, USA). This recombi-nant pRB has also been shown to cause cell cycle arrest when microinjected into cancer cells (Pagliaro et al., 1995) .
Plasmids and transfection
The tetracycline-repressor gene expression system was used to induce expression of the CKI's, p16, p21 and p27. The pUHD-15-1neo plasmid contains the E. coli tetracycline repressor element fused to the VP16 transactivation domain of herpes virus. This fusion protein is driven by a CMV promoter and the vector has the neomycin resistance gene for selection. pUHD15-1neo (25 mg) was transfected into U343 cells using the calcium phosphate method. Clones were selected in 900 mg/mL gentecin (Gibco/BRL) in a-MEM and stable expression of the fusion protein was determined by Western blot analysis of total cell lysates using a polyclonal antisera to VP16 (kind gift of Dr J Ingles, Univ. Toronto). Twenty clones were analysed for VP16 expression and the majority expressed VP16. One clone, which demonstrated high level expression of VP16 (clone 88) was selected for transfection with pUHD10-3. pUHD10-3 contains a multiple cloning site downstream from tandem tetracycline operator sequences and a CMV promoter. Full length human cDNAs of p16, p21 (gifts of D Beach) and p27 (gift of J Massague) were inserted into the multiple cloning site of pUHD10-3, and this plasmid (25 mg) was cotransfected with pgk-puro (0.5 mg) for selection of stable lines. These clones were also maintained in 4 mg/mL tetracycline added from a 4 mg/mL stock in 70% ethanol. Puromycin was used for selection at 1 mg/mL, and G418 concentration was maintained at 500 mg/mL.
To induce expression of CKI's, cells were washed three times in PBS, before identical media without tetracycline was added. To screen for CKI expression, total cell lysates were collected and Western blot analysis was performed for p16, p21 or p27. To determine the eect of induction of CKI expression on the growth and morphology of U343 cells, 2 ± 5610 5 cells were plated in 100 mm 2 dishes. The following day, fresh media was placed and cell proliferation assays and¯ow cytometric analysis were performed as described.
